MyAverix Finance
F · Healthcare
Cosmo Pharmaceuticals N.V (C43)
Drug Manufacturers - General
Cosmo Pharmaceuticals N.V (C43) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-28, reported market cap is $1.48B, P/E ratio is 18.00, net margin is -3.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for C43
Cosmo Pharmaceuticals N.V (C43) — FAQ
What is Cosmo Pharmaceuticals N.V's market cap?
Cosmo Pharmaceuticals N.V (C43) has a reported market cap of $1.48B (data as of 2026-03-28).
What is C43's P/E ratio?
The price-to-earnings (P/E) ratio for Cosmo Pharmaceuticals N.V (C43) is 18.00 (data as of 2026-03-28).
Does Cosmo Pharmaceuticals N.V pay a dividend?
Dividend yield is not available in the current snapshot for Cosmo Pharmaceuticals N.V (C43). Check the MyAverix Finance app for the latest dividend data.
What sector is Cosmo Pharmaceuticals N.V in?
Cosmo Pharmaceuticals N.V (C43) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is C43 listed on?
C43 is listed on F.
What is Cosmo Pharmaceuticals N.V's net margin?
Cosmo Pharmaceuticals N.V (C43) reports a net margin of -3.5% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.